|
|||||
|
|

Insurance data analytics provider Verisk Analytics (NASDAQ:VRSK) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 5.9% year on year to $778.8 million. On the other hand, the company’s full-year revenue guidance of $3.22 billion at the midpoint came in 1.6% below analysts’ estimates. Its non-GAAP profit of $1.82 per share was 12.9% above analysts’ consensus estimates.
Is now the time to buy VRSK? Find out in our full research report (it’s free for active Edge members).
Verisk’s fourth quarter drew a positive market response, reflecting management’s focus on data-driven analytics and technology enhancement for the insurance sector. CEO Lee Shavel pointed to robust growth in subscription-based products, especially in underwriting and catastrophe solutions, despite subdued transactional revenue linked to muted weather activity. The sale of Verisk Marketing Solutions and the termination of the AccuLinks acquisition marked significant portfolio moves, with Shavel stating these actions reinforce Verisk’s commitment to core data and analytics offerings. Notably, new AI-powered claims tools like ExactGen and Exact AI were highlighted as drivers of operational efficiency and customer engagement.
Looking ahead, management’s guidance emphasizes ongoing investment in AI and digital innovation as key to Verisk’s growth strategy. Shavel underscored the company’s plans to expand its suite of AI-driven solutions, citing over 35 current projects and a pipeline of new modules for 2026. CFO Elizabeth Mann cautioned that a softer pricing environment and temporary headwinds, such as lower weather-related volumes and government contract pauses, may temper near-term growth. However, Shavel maintained that Verisk’s established data infrastructure and integration with client workflows position the company to support insurers’ evolving needs, stating, “We are well positioned to benefit from AI, drive new innovation, and further connect the insurance ecosystem.”
Management attributed the quarter's performance to resilient subscription revenue growth, product innovation in claims and underwriting, and a sharpened focus following divestitures.
Management expects Verisk’s growth to be shaped by AI product expansion, evolving insurance industry technology adoption, and disciplined portfolio management.
Our analyst team will be monitoring (1) adoption rates and client value realization from new AI-powered claims products like ExactGen and Exact AI, (2) the pace of Coreline Reimagine module deployment and client training, and (3) recovery in transactional revenue as weather activity and government contract volumes normalize. Additionally, we will track the impact of portfolio simplification and continued investment in proprietary data infrastructure on Verisk’s competitive positioning.
Verisk currently trades at $185.20, up from $177.30 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
| Mar-11 | |
| Mar-10 | |
| Mar-09 | |
| Mar-09 | |
| Mar-06 | |
| Mar-05 | |
| Mar-05 | |
| Feb-26 | |
| Feb-25 | |
| Feb-23 | |
| Feb-23 | |
| Feb-23 | |
| Feb-23 | |
| Feb-21 | |
| Feb-20 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about Finviz Elite